(ITP) Interparfums - Ratings and Ratios
Perfumes, Cosmetics, Fragrances, Fashion, Skincare
ITP EPS (Earnings per Share)
ITP Revenue
Description: ITP Interparfums
Interparfums SA is a leading player in the global perfume and cosmetics industry, leveraging license agreements with prominent brands to design, manufacture, and distribute its products across various regions, including Europe, the Americas, Africa, and Asia.
The companys diversified portfolio includes iconic brands such as Boucheron, Coach, Jimmy Choo, and Montblanc, among others, which are distributed through a mix of wholly owned subsidiaries, joint ventures, and independent companies, enabling a strong presence in both the prestige and mass markets.
From a financial perspective, Interparfums SA has demonstrated a strong Return on Equity (RoE) of 31.61%, indicating effective use of shareholder capital. With a market capitalization of 2802.06M EUR, the company has a significant presence in the Personal Care Products sub-industry. The current Price-to-Earnings (P/E) ratio of 20.31 suggests a reasonable valuation, although the forward P/E of 58.14 may indicate expected growth in earnings.
To further evaluate the companys performance, additional KPIs such as revenue growth, gross margin, and operating margin could be analyzed. For instance, a high gross margin would indicate the companys ability to maintain pricing power and manage its cost of goods sold effectively. Moreover, an analysis of the companys debt-to-equity ratio and interest coverage ratio could provide insights into its capital structure and ability to service its debt.
From a growth perspective, Interparfums SAs presence in emerging markets, such as Asia and Eastern Europe, could be a key driver of future revenue growth. The companys ability to expand its portfolio of licensed brands and maintain strong relationships with its partners will be crucial in driving long-term success.
ITP Stock Overview
| Market Cap in USD | 3,216m |
| Sub-Industry | Personal Care Products |
| IPO / Inception |
ITP Stock Ratings
| Growth Rating | -9.97% |
| Fundamental | 86.4% |
| Dividend Rating | 68.8% |
| Return 12m vs S&P 500 | -31.2% |
| Analyst Rating | - |
ITP Dividends
| Dividend Yield 12m | 3.14% |
| Yield on Cost 5y | 4.89% |
| Annual Growth 5y | 29.10% |
| Payout Consistency | 92.6% |
| Payout Ratio | 58.4% |
ITP Growth Ratios
| Growth Correlation 3m | -67.8% |
| Growth Correlation 12m | -71.4% |
| Growth Correlation 5y | 30.7% |
| CAGR 5y | 7.98% |
| CAGR/Max DD 5y | 0.18 |
| Sharpe Ratio 12m | -0.13 |
| Alpha | -30.07 |
| Beta | 0.487 |
| Volatility | 34.40% |
| Current Volume | 22.5k |
| Average Volume 20d | 26k |
| Stop Loss | 30.6 (-3.1%) |
| Signal | 0.22 |
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (205.9m TTM) > 0 and > 6% of Revenue (6% = 89.7m TTM) |
| FCFTA 0.15 (>2.0%) and ΔFCFTA 6.78pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 25.43% (prev 28.22%; Δ -2.78pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 146.1m <= Net Income 205.9m (YES >=105%, WARN >=100%) |
| Net Debt (-35.6m) to EBITDA (320.7m) ratio: -0.11 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (69.2m) change vs 12m ago -8.93% (target <= -2.0% for YES) |
| Gross Margin 66.13% (prev 65.10%; Δ 1.04pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 149.3% (prev 122.2%; Δ 27.12pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.21 (EBITDA TTM 320.7m / Interest Expense TTM 35.0m) >= 6 (WARN >= 3) |
Altman Z'' 5.92
| (A) 0.37 = (Total Current Assets 596.4m - Total Current Liabilities 216.3m) / Total Assets 1.03b |
| (B) 0.13 = Retained Earnings (Balance) 129.9m / Total Assets 1.03b |
| (C) 0.29 = EBIT TTM 287.7m / Avg Total Assets 1.00b |
| (D) 1.11 = Book Value of Equity 370.7m / Total Liabilities 334.4m |
| Total Rating: 5.92 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.39
| 1. Piotroski 8.0pt = 3.0 |
| 2. FCF Yield 5.87% = 2.94 |
| 3. FCF Margin 10.64% = 2.66 |
| 4. Debt/Equity 0.20 = 2.48 |
| 5. Debt/Ebitda 0.43 = 2.36 |
| 6. ROIC - WACC 19.19% = 12.50 |
| 7. RoE 31.61% = 2.50 |
| 8. Rev. Trend 44.15% = 2.21 |
| 9. Rev. CAGR 17.40% = 2.17 |
| 10. EPS Trend 42.85% = 1.07 |
| 11. EPS CAGR 41.41% = 2.50 |
What is the price of ITP shares?
Over the past week, the price has changed by -4.36%, over one month by -2.11%, over three months by -6.21% and over the past year by -19.76%.
Is Interparfums a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ITP is around 27.85 EUR . This means that ITP is currently overvalued and has a potential downside of -11.81%.
Is ITP a buy, sell or hold?
What are the forecasts/targets for the ITP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 39.1 | 23.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31 | -1.8% |
ITP Fundamental Data Overview
Market Cap EUR = 2.76b (2.76b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 190.6m EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 20.2577
P/E Forward = 58.1395
P/S = 3.1359
P/B = 3.9181
Beta = 1.064
Revenue TTM = 1.49b EUR
EBIT TTM = 287.7m EUR
EBITDA TTM = 320.7m EUR
Long Term Debt = 95.9m EUR (from longTermDebt, last quarter)
Short Term Debt = 40.7m EUR (from shortTermDebt, last quarter)
Debt = 136.6m EUR (Calculated: Short Term 40.7m + Long Term 95.9m)
Net Debt = -35.6m EUR (from netDebt column, last quarter)
Enterprise Value = 2.71b EUR (2.76b + Debt 136.6m - CCE 190.6m)
Interest Coverage Ratio = 8.21 (Ebit TTM 287.7m / Interest Expense TTM 35.0m)
FCF Yield = 5.87% (FCF TTM 159.0m / Enterprise Value 2.71b)
FCF Margin = 10.64% (FCF TTM 159.0m / Revenue TTM 1.49b)
Net Margin = 13.78% (Net Income TTM 205.9m / Revenue TTM 1.49b)
Gross Margin = 66.13% ((Revenue TTM 1.49b - Cost of Revenue TTM 506.0m) / Revenue TTM)
Tobins Q-Ratio = 7.30 (Enterprise Value 2.71b / Book Value Of Equity 370.7m)
Interest Expense / Debt = 25.64% (Interest Expense 35.0m / Debt 136.6m)
Taxrate = 25.41% (from yearly Income Tax Expense: 44.4m / 174.7m)
NOPAT = 214.6m (EBIT 287.7m * (1 - 25.41%))
Current Ratio = 2.76 (Total Current Assets 596.4m / Total Current Liabilities 216.3m)
Debt / Equity = 0.20 (Debt 136.6m / last Quarter total Stockholder Equity 697.0m)
Debt / EBITDA = 0.43 (Net Debt -35.6m / EBITDA 320.7m)
Debt / FCF = 0.86 (Debt 136.6m / FCF TTM 159.0m)
Total Stockholder Equity = 651.3m (last 4 quarters mean)
RoA = 19.93% (Net Income 205.9m, Total Assets 1.03b )
RoE = 31.61% (Net Income TTM 205.9m / Total Stockholder Equity 651.3m)
RoCE = 38.51% (Ebit 287.7m / (Equity 651.3m + L.T.Debt 95.9m))
RoIC = 27.53% (NOPAT 214.6m / Invested Capital 779.6m)
WACC = 8.34% (E(2.76b)/V(2.90b) * Re(7.81%)) + (D(136.6m)/V(2.90b) * Rd(25.64%) * (1-Tc(0.25)))
Shares Correlation 5-Years: -40.0 | Cagr: -0.63%
Discount Rate = 7.81% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 73.23% ; FCFE base≈128.8m ; Y1≈96.2m ; Y5≈56.9m
Fair Price DCF = 12.86 (DCF Value 1.08b / Shares Outstanding 83.6m; 5y FCF grow -29.99% → 3.0% )
Revenue Correlation: 44.15 | Revenue CAGR: 17.40%
Rev Growth-of-Growth: 11.06
EPS Correlation: 42.85 | EPS CAGR: 41.41%
EPS Growth-of-Growth: -1.07